Steve A. Campbell

Steve A. Campbell has over 25 years of work experience in the biotechnology and pharmaceutical industry. Steve A. is currently the Head of Supplier and Vendor Management at Lyell Immunopharma, where they are responsible for designing, implementing, and executing the supplier and vendor oversight program. This includes assessing GxP suppliers and conducting audits to ensure compliance with regulatory requirements.

Prior to their current role, Steve worked as a GxP Principal Auditor at Karyopharm Therapeutics Inc. and as the QA Head for Deviation Investigations CAPA at AGC Biologics. At Bristol Myers Squibb, they served as the Manager of QA Deviation Investigations CAPA.

Steve also has an extensive tenure at Genentech, where they held various senior positions. This includes being the Senior Technical Manager for Supplier Quality Biologics, where they managed direct material suppliers for biologics manufacturing. Steve A. also served as the Senior Technical Manager for Multi-Site Change Control & Network Operations, responsible for administering the change control system across global manufacturing sites.

Earlier in their career, Steve worked at Bayer as a Senior Biotechnician in fermentation, and at 5 Star American Transformer Services as a Laboratory Analyst.

Throughout their career, Steve has demonstrated expertise in quality assurance, deviation investigations, change control, supplier management, and audit compliance.

Steve A. Campbell attended Solano Community College from 1994 to 1997, where they studied Biology. After completing their studies at Solano Community College, Steve went on to pursue a Bachelor of Science degree in Quality Assurance at California State University-Dominguez Hills.